tk88 bet

ADB, Imexpharm sign loan to support generic medicine production in Vietnam

The Asian Development Bank (ADB) signed an eight million USD loan with Imexpharm Corporation to help the company sustain its production of generic medicines despite global supply disruptions caused by the COVID-19 pandemic.
ADB, Imexpharm sign loan to support generic medicine production in Vietnam ảnh 1The Asian Development Bank (ADB) signed an eight million USD loan with Imexpharm Corporation to help the company sustain its production of generic medicines (Photo: baodautu.vn)

 Hanoi (VNA) -🎶 The AsianDevelopment Bank (ADB) signed an eight million USD loan with ImexpharmCorporation to help the company sustain its production of generic medicinesdespite global supply disruptions caused by the COVID-19 pandemic.

The financing will support the company’sworking capital needs to ensure ample supply of active pharmaceuticalingredients for essential generic medicine production. Imexpharm’s operations and continuedproduction of generic pharmaceuticals and their ensured availability in themarket is integral in safeguarding the country’s health care during thepandemic. Head of Health and Education Investments atADB's Private Sector Operations Department Aniruddha Patil said that Asia haswitnessed disruptions across the pharmaceutical supply chain in 2020, includinga shortage of active pharmaceutical ingredients. “This project demonstrates ADB’s continuedefforts to enhance health outcomes in Vietnam by encouraging the developmentand use of local generic medicines,” he added. For his part, Imexpharm’s Chairman NguyenQuoc Dinh said that the financing will improve the firm’s liquidity situationand ensure a consistent supply of affordable generic drugs to hospitals andpharmacies across Vietnam. This debt financing is part of ADB’s 20billion USD assistance announced on April 13 to help its developing membersmanage the pandemic. Imexpharm was established in 1977 andinitially incorporated in 1983 as the Dong Thap Pharmaceutical Union. The firmwas transformed from a state-owned enterprise into a joint-stock company andrenamed Imexpharm Corporation, and its shares were listed on the Ho Chi MinhStock Exchange in December 2006. As of September 30, Imexpharm had 1,252 employees,total assets of 2.07 trillion VND (89.66 million USD), and six pharmaceuticalmanufacturing facilities./.
VNA

See more

Assoc. Prof. Dr Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi, speaks online on Vietnam’s digital transformation strategy in medical education. (Photo: VNA)

🧜 Forum spotlights AI and digital innovation in healthcare

To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
A banner on the side of a car urges people to quit smoking for their own health and that of their loved ones (Photo: VNA)

🌌 Sharp tobacco tax hike urged to safeguard youths, community health

A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|